Previous Close | $80.65 |
Intrinsic Value | $0.00 |
Upside potential | -100% |
Data is not available at this time.
MetLife, Inc. is a leading global provider of insurance, annuities, and employee benefit programs, operating across life, accident & health, and retirement solutions. The company serves a diverse clientele, including individuals, corporations, and institutions, leveraging its extensive distribution network and strong brand recognition. MetLife’s revenue model is anchored in premium income, investment returns, and fee-based services, with a focus on underwriting discipline and risk management to sustain profitability. The firm competes in a mature but highly regulated industry, where scale, diversification, and operational efficiency are critical differentiators. Its market position is reinforced by a robust international presence, particularly in Asia and Latin America, which provides growth opportunities beyond its core U.S. market. MetLife’s ability to cross-sell products and adapt to evolving customer needs—such as digital engagement and workplace benefits—positions it as a resilient player in the insurance sector.
MetLife reported $69.9 billion in revenue for FY 2024, with net income of $4.4 billion, reflecting a net margin of approximately 6.3%. The company generated $14.6 billion in operating cash flow, underscoring strong liquidity from premiums and investments. Notably, capital expenditures were negligible, indicating a capital-light model focused on underwriting and asset management rather than heavy infrastructure investments.
Diluted EPS stood at $5.94, demonstrating MetLife’s ability to translate top-line growth into shareholder returns. The absence of significant capex highlights capital efficiency, with earnings primarily driven by underwriting performance and investment income. The firm’s focus on optimizing its portfolio and managing risk-adjusted returns supports consistent earnings power despite macroeconomic volatility.
MetLife maintains a solid balance sheet, with $20.1 billion in cash and equivalents against $18.7 billion in total debt, reflecting prudent liquidity management. The debt-to-equity ratio appears manageable, supported by steady cash flows from operations. The company’s financial health is further reinforced by its ability to meet policyholder obligations and maintain regulatory capital requirements.
Growth has been steady, with a focus on expanding high-margin segments like group benefits and retirement solutions. MetLife’s dividend policy remains shareholder-friendly, with a $2.44 annual dividend per share, offering a yield competitive within the insurance sector. The company balances reinvestment for growth with consistent returns to investors.
MetLife’s valuation reflects its stable earnings and defensive positioning in the insurance industry. Market expectations likely hinge on its ability to sustain underwriting margins and navigate interest rate fluctuations, which impact investment income. The stock’s performance will depend on execution in international markets and cost management.
MetLife’s scale, diversified product suite, and global footprint provide strategic advantages in a competitive landscape. The outlook remains cautiously optimistic, with growth initiatives in digital transformation and emerging markets offsetting challenges like regulatory pressures and economic uncertainty. The company’s disciplined risk management and strong brand equity position it for long-term resilience.
Company filings (10-K), investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |